SOLV Company Profile and Key Details

NYSE : SOLV

Solventum

$63.57

-0.78-1.21%

Open: 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Solventum Corporation (SOLV) stock declined over -1.21%, trading at $63.57 on NYSE, down from the previous close of $64.35. The stock opened at $62.91, fluctuating between $62.67 and $64.49 in the recent session.

Stock Snapshot

64.35

Prev. Close

11.03B

Market Cap

62.665

Day Low

7.16

P/E Ratio

8.88

EPS (TTM)

N/A

Cash Flow per Share

62.91

Open

173.49M

Number of Shares

64.49

Day High

85.05%

Free Float in %

N/A

Book Value

800.01K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2026	63.36	64.49	62.67	63.57	1.03M
Apr 01, 2026	65.49	66.06	64.33	64.35	1.43M
Mar 31, 2026	64.42	65.64	63.35	65.30	2.12M
Mar 30, 2026	63.38	63.85	63.07	63.45	1.53M
Mar 27, 2026	64.32	64.32	62.65	62.76	1.35M
Mar 25, 2026	64.59	65.23	63.13	64.64	1.06M
Mar 24, 2026	64.00	64.86	62.80	64.03	1.68M
Mar 23, 2026	67.08	67.46	65.67	65.69	1.83M
Mar 20, 2026	67.05	67.10	65.13	65.78	2.39M
Mar 19, 2026	66.73	67.89	66.67	67.14	1.18M
Mar 18, 2026	68.00	68.58	67.06	67.10	1.02M
Mar 17, 2026	68.01	69.11	68.01	68.67	1.15M
Mar 16, 2026	67.57	68.70	66.97	67.14	1.64M
Mar 13, 2026	66.74	67.37	66.17	66.76	1.88M
Mar 12, 2026	67.21	68.67	65.65	66.12	1.69M
Mar 11, 2026	67.68	68.02	66.80	67.62	953.4K
Mar 10, 2026	68.35	68.63	67.11	67.60	1.04M
Mar 09, 2026	68.29	68.85	66.61	68.60	1.34M
Mar 06, 2026	70.00	70.44	68.99	69.41	1.28M
Mar 03, 2026	72.00	72.16	70.57	70.81	1.09M

Contact Details

Maplewood, MN 55144

United States

https://www.solventum.com 651 733 1110

About Company

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Stock Peers

HCA

-2.91-0.61%

HCA Healthcare, Inc.$471.84 CHE

3.03+0.80%

Chemed Corporation$380.60 THC

-2.1-1.10%

Tenet Healthcare Corporation$188.17 UHS

-1.24-0.70%

Universal Health Services, Inc.$176.70 DVA

-4.76-3.17%

DaVita Inc.$145.58 EHC

0.01+0.01%

Encompass Health Corporation$97.39 BKDT

-2.09-2.62%

Brookdale Senior Living Inc. 7.$77.60 USPH

-0.66-0.89%

U.S. Physical Therapy, Inc.$73.74 SNDA

0.07999924+0.25%

Sonida Senior Living, Inc.$32.18 FMS

0.06+0.27%

Fresenius Medical Care AG & Co. KGaA$22.41

Company Overview

Solventum Corporation (NYSE:SOLV) closed at $63.57 USD, losing -$0.78 (-1.21%) from the previous close of $64.35. The stock is currently within 5% of its 52-week low $60.70 and $88.20. With a market capitalization of about $11.03 billion, Solventum Corporation is classified as a large-cap and shows lower-than-market volatility (beta ~0.77). Key stats such as the average daily volume over the past year has been around 1.24 million shares, volume is running light vs its 52-week average. Headquartered in Maplewood, MN, Solventum Corporation operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Bryan C. Hanson, the company employs approximately 22,000 people and listed since April 01, 2024. Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 1.07%, SMA50 -2.49%, SMA200 2.01%). The stock’s 14-day RSI is 50.79 (neutral), while the ATR of 2.09 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -12.77% below its high and over 26.75% above its low. Average 10-day trading volume of 1.49 million shares is slightly above the 3-month average of 1.20 million, indicating heightened recent market interest.

Valuation Metrics

Solventum Corporation trades at a P/E ratio of 7.11, slightly below the S&P 500 average, with a price-to-sales ratio of 1.32 and a price-to-book ratio of 2.19 suggesting the stock is closer to book value. The P/FCF stands at -1102.9, also below market averages.

Dividend & Fair Value

Solventum Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $103.62. This means the shares are trading below this model’s fair value.

Shareholding & Insider Activity

Solventum Corporation has 173.39 million shares outstanding. The public float is 147.51 million shares, elevated short interest at 2.77% of float. This equals 3.85 million shares. The short ratio is 3.8 days. Institutional investors hold 85.19% of the float. Insiders own 14.91%. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Solventum has not generated any revenue.
On valuation metrics, Solventum trades at a P/E of 7.11, P/S of 1.32 and P/B of 2.19. The current ratio is 1.23 and quick ratio is 0.89. Operationally, the company’s inventory turnover is 3.63 and cash conversion cycle is 81.04 days. Debt-to-equity is 1.00, supported by a cash flow-to-debt ratio of 0.07.

Price Forecast & Outlook

Our AI price prediction model suggests that Solventum Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.21%, with price expected at $59.62 by April 16, 2026, within a range of $57.78 to $61.62 3-Month Outlook: Projected fall of -2.49%, reaching $61.99 by July 01, 2026, with a range of $57.42 to $65.18. 1-Year Outlook: Projected gain of 27.45%, with price at $81.02 by April 02, 2027, within a range of $79.53 to $82.73.

Key Takeaways

Solventum Corporation (NYSE:SOLV) shares are flat -0.35% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Solventum Corporation trading at a premium to the broader market with a P/E of 7.11. Analyst sentiment is cautious, with the majority of ratings in Sell territory and a mean price target of $82.38, suggesting 29.59% upside. Our AI forecast model points to short-term weakness (-6.21% over two weeks), a medium-term fall (-2.49% over three months), and a longer-term gain (27.45% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Solventum Corporation (SOLV) stock price?

Solventum Corporation (NYSE: SOLV) stock price is $63.57 in the last trading session. During the trading session, SOLV stock reached the peak price of $64.49 while $62.67 was the lowest point it dropped to. The percentage change in SOLV stock occurred in the recent session was -1.21% while the dollar amount for the price change in SOLV stock was - $0.78.

SOLV's industry and sector of operation?

The NYSE listed SOLV is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. Solventum Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SOLV?

No Data

How SOLV did perform over past 52-week?

SOLV's closing price is 4.73% higher than its 52-week low of $60.70 where as its distance from 52-week high of $88.20 is -27.93%.

How many employees does SOLV have?

Number of SOLV employees currently stands at 22,000.

Link for SOLV official website?

Official Website of SOLV is: https://www.solventum.com

How do I contact SOLV?

SOLV could be contacted at phone 651 733 1110 and can also be accessed through its website. SOLV operates from 3M Center, Maplewood, MN 55144, United States.

How many shares of SOLV are traded daily?

SOLV stock volume for the day was 800.01K shares. The average number of SOLV shares traded daily for last 3 months was 1.24M.

What is the market cap of SOLV currently?

The market value of SOLV currently stands at $11.03B with its latest stock price at $63.57 and 173.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	22000
Beta	0.54
Sales or Revenue	N/A
5Y Sales Change%	0.124%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Medical - Care Facilities

SOLV Company Profile and Key Details

Solventum

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Key Takeaways

Price Forecast & Outlook

Financial & Profitability Overview

Company Overview

Shareholding & Insider Activity

Valuation Metrics